Indications for FLUZONE INTRADERMAL QUADRIVALENT:
18–64yrs: One dose per year. 0.1mL intradermally in the deltoid region.
<18yrs: not established. Use Fluzone IM.
Allergy to egg proteins. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Have epinephrine inj (1:1000) available. Pregnancy (Cat.C for High-Dose; Cat.B for Intradermal Quadrivalent). Nursing mothers.
Immunosuppressants: may get suboptimal response.
Local reactions (eg, pain, tenderness, swelling, erythema), malaise, headache, myalgia, irritability.
Fluzone, Fluzone Quadrivalent prefilled syringe (0.25mL, 0.5mL)—10; Single-dose vial (0.5mL)—10; Fluzone, Fluzone Quadrivalent multi-dose vial (5mL)—1 (contains thimerosal); Fluzone High-Dose prefilled syringe (0.5mL)—10; Fluzone Intradermal Quadrivalent single-dose prefilled microinjection system (0.1mL)—10